(Q43206159)
Statements
Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer (English)
Jacek Jassem
1 reference
Flavia Morales-Vasquez
Luis M Zetina
Maria de Fátima Dias Gaui
Douglas Otero Reyes
Claire Barton
Peter Button
Veronica Hersberger
Antonio Antón Torres